Stem Cell Innovations to Provide Research and Assay Services to Agennix Inc.
3/2/2010 9:10:02 AM
More...
|
FDA's Hydroxycut Recall Highlights the Need for Stem Cell Innovations' ACTIVTox Human Liver Testing
5/21/2009 9:20:38 AM
More...
|
Stem Cell Innovations' C3A Human Liver Cell Line is Capable of Producing Biosimilar Serum Proteins for Follow-On Biologics
2/25/2009 11:27:59 AM
More...
|
Stem Cell Innovations' PluriCells(TM) to Form the Basis of a Liver Assist Device to Support Patients Waiting for Transplant
2/5/2009 11:41:56 AM
More...
|
Stem Cell Innovations Files New Patent Application Regarding Pluripotent Stem Cell Production
1/23/2009 8:54:23 AM
More...
|
Stem Cell Innovations Cites Two Recent Government Documents Supporting the Use of Cell-Based Assays for Toxicity Testing
10/23/2007 9:37:07 AM
More...
|
Stem Cell Innovations and High Q Foundation Collaborate to Develop Novel Models of Huntington's Disease
6/25/2007 12:45:11 PM
More...
|
Stem Cell Innovations and TNO to Collaborate on Generating PluriCell Derived Cartilage and Cardiomyocytes; Awarded Dutch EZ-Cofinancing Grant
5/30/2007 1:34:56 PM
More...
|
Stem Cell Innovations Patents on Pluripotent Cells Cited by the U.S. Patent and Trademark Office as Prior Art, Pre-Dating the WARF and Thomson Core Embryonic Stem Cell Patents
4/10/2007 12:39:57 PM
More...
|
Stem Cell Innovations to Validate Circomed AG's Cardiovascular Compounds Using Its C3A Human Liver Cell System
3/27/2007 12:43:36 PM
More...
|
|